Definitive Healthcare (NASDAQ:DH – Get Free Report) issued an update on its third quarter 2026 earnings guidance on Monday. The company provided EPS guidance of 0.040-0.050 for the period, compared to the consensus EPS estimate of 0.040. The company issued revenue guidance of $54.0 million-$55.0 million, compared to the consensus revenue estimate of $55.5 million. Definitive Healthcare also updated its FY 2026 guidance to 0.180-0.200 EPS.
Definitive Healthcare Price Performance
DH stock traded down $0.01 during trading on Monday, reaching $0.70. 172,029 shares of the company were exchanged, compared to its average volume of 358,377. The stock’s 50 day moving average price is $0.78 and its 200 day moving average price is $1.12. The company has a market cap of $73.71 million, a P/E ratio of -0.43, a PEG ratio of 11.51 and a beta of 1.35. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.75 and a current ratio of 1.75. Definitive Healthcare has a 52-week low of $0.62 and a 52-week high of $4.35.
Definitive Healthcare (NASDAQ:DH – Get Free Report) last released its quarterly earnings data on Thursday, May 7th. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.03. Definitive Healthcare had a positive return on equity of 4.04% and a negative net margin of 76.04%.The firm had revenue of $55.93 million during the quarter, compared to the consensus estimate of $55.02 million. As a group, analysts predict that Definitive Healthcare will post 0.04 earnings per share for the current fiscal year.
Analysts Set New Price Targets
Check Out Our Latest Stock Report on DH
Institutional Trading of Definitive Healthcare
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Raymond James Financial Inc. acquired a new position in Definitive Healthcare in the 2nd quarter valued at about $32,000. Schonfeld Strategic Advisors LLC acquired a new stake in shares of Definitive Healthcare during the 4th quarter worth about $35,000. HRT Financial LP acquired a new stake in shares of Definitive Healthcare during the 4th quarter worth about $47,000. ExodusPoint Capital Management LP purchased a new stake in shares of Definitive Healthcare during the fourth quarter worth about $47,000. Finally, Bayesian Capital Management LP purchased a new stake in shares of Definitive Healthcare during the second quarter worth about $55,000. Hedge funds and other institutional investors own 98.67% of the company’s stock.
Definitive Healthcare Company Profile
Definitive Healthcare (NASDAQ:DH) is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.
The company’s flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.
Read More
- Five stocks we like better than Definitive Healthcare
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
- First Solar’s Profit Engine Faces a New Policy Test in Washington
Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
